UNSPSC 51392416: Ibopamine hydrochloride

This classification denotes a vasodilating agent with the molecular formula C17H25NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3VXW2HU8GS, chemically known as propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester but more generally known as ibopamine, which bears US NIH Compound Identifier 68555. European Medicines Agency schedules Ibopamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08094MIG. The term IBOPAMINE HYDROCHLORIDE is an International Non-Proprietary Name.

UNSPSC 51392416 Ibopamine hydrochloride is a Commodity code that nominally covers a specific pharmaceutical compound, but recent state and local procurement activity under this code does not align with that scope. Seminole County, Florida posted IFB 60459723LAS seeking to procure naloxone and drug deactivation systems—emergency response and harm-reduction products—rather than ibopamine hydrochloride. The mismatch suggests either miscoding by the issuing body or a data-capture error in the opportunity record. The naloxone procurement itself reflects typical county health department purchasing: competitive sealed bids, multi-year terms with renewal options, quarterly deliveries to a named facility, and standard contractor compliance requirements including E-Verify, drug-free workplace certification, and insurance.

Based on the single recent opportunity identified, the code shows minimal relevant activity in state and local procurement. Seminole County's posting on June 30, 2026, with a July 26, 2026, response deadline, represents the only recent solicitation captured under this code, and it does not reflect the actual commodity the code purports to cover. Before committing resources to pursuit under UNSPSC 51392416, verify with prospective customers whether they use this code intentionally for ibopamine hydrochloride procurement or whether miscoding has skewed the record. If the code is actively used for pharmaceutical procurement in your target jurisdictions, monitor for future opportunities; if the mismatch is systemic, the code warrants lower priority relative to adjacent pharmaceutical or emergency-response categories that reflect actual buying patterns.